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Abstract
Elevated circulating lipid levels are known risk factors for cardiovascular diseases (CVD). In order to examine the effects of
quercetin on lipid metabolism, mice received a mild-high-fat diet without (control) or with supplementation of 0.33% (w/w)
quercetin for 12 weeks. Gas chromatography and 1H nuclear magnetic resonance were used to quantitatively measure
serum lipid profiles. Whole genome microarray analysis of liver tissue was used to identify possible mechanisms underlying
altered circulating lipid levels. Body weight, energy intake and hepatic lipid accumulation did not differ significantly
between the quercetin and the control group. In serum of quercetin-fed mice, triglycerides (TG) were decreased with 14%
(p,0.001) and total poly unsaturated fatty acids (PUFA) were increased with 13% (p,0.01). Palmitic acid, oleic acid, and
linoleic acid were all decreased by 9–15% (p,0.05) in quercetin-fed mice. Both palmitic acid and oleic acid can be oxidized
by omega (v)-oxidation. Gene expression profiling showed that quercetin increased hepatic lipid metabolism, especially v-
oxidation. At the gene level, this was reflected by the up-regulation of cytochrome P450 (Cyp) 4a10, Cyp4a14, Cyp4a31 and
Acyl-CoA thioesterase 3 (Acot3). Two relevant regulators, cytochrome P450 oxidoreductase (Por, rate limiting for
cytochrome P450s) and the transcription factor constitutive androstane receptor (Car; official symbol Nr1i3) were also up-
regulated in the quercetin-fed mice. We conclude that quercetin intake increased hepatic lipid v-oxidation and lowered
corresponding circulating lipid levels, which may contribute to potential beneficial effects on CVD.
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Introduction
Cardiovascular diseases (CVD) are globally the most important
cause of mortality. High consumption of fruits and vegetables are
thought to be protective against CVD [1]. These protective effects
have been suggested to be mediated by the flavonoid content of
fruits and vegetables [2]. Various classes of flavonoids are common
in plant foods, one being the flavonols. Quercetin is the major
dietary flavonol in the Western diet, which is present in, for
example, apples, tea, red wine and onions. Epidemiological studies
have shown that the intake of this dietary flavonoid is associated
with a reduction of CVD risk [3,4,5].
Elevated circulating levels of free fatty acids (FFA) and
triglycerides (TG) are known risk factors for CVD [6,7,8,9]. In
particular, increased levels of FFA and TG are associated with
atherosclerosis, ischemic damage, pro arrhythmia, myocardial
infarction, and heart failure. Accumulation of toxic lipid interme-
diates, suppression of glucose usage, or mitochondrial dysfunction
potentially play a role in these effects [9]. Several studies showed
that supplementation of quercetin to the diet decreased serum FFA
and/or TG levels in rodents [10,11,12]. The cardio protective
properties of quercetin may therefore be explained by the lipid
lowering effect of quercetin. However, in these studies the FFA
and TG levels were measured with enzyme-based assays.
Recently, we have shown that flavonoids interfere with these
enzymatic FFA and TG assays, which will lead to incorrect,
apparently lower FFA and TG levels [13]. Therefore, it can be
questioned whether quercetin has a true biological effect on lipid
metabolism. Since various fatty acids are differently associated
with CVD risk, it is also important to examine whether quercetin
changes specific lipids [14]. Furthermore, based on gene
expression analysis some genes have been put forward to explain
the effects of quercetin on lipid metabolism [11,12], but these
results are not conclusive. The aim of the present study was to re-
examine the effects of quercetin on lipid metabolism, with state-of-
the-art analytical techniques, to exclude any interference of
quercetin in the measeruments. Gas chromatography (GC) and
a novel technique, 1H-nuclear magnetic resonance (1H-NMR)
lipid profiling of mouse serum (based on [15,16]), were used to
profile and quantify different serum lipids. In addition, whole
genome microarray gene expression analysis of liver tissues was
applied to unravel the possible underlying mechanisms. For this
gene expression analysis the liver was chosen as target organ, since
it is one of the major effector organs of lipid metabolism. This
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principal combination of profiling of serum lipids and gene
expression were used to investigate the mechanisms of action of
quercetin on lipid metabolism.
The results show that a quercetin supplemented mild-high-fat
diet in mice increased hepatic lipid metabolism, especially omega
(v)-oxidation and reduced corresponding circulating lipid levels.
These results contribute to the understanding of the protective
properties of quercetin on CVD.
Materials and Methods
Animals and Treatments
Twenty-four male C57BL/6JOlaHsd mice (Harlan Laborato-
ries, Horst, The Netherlands) were individually housed and
maintained under environmentally controlled conditions (temper-
ature 21uC, 12 h/12 h light-dark cycle, 45% humidity). The mice
had ad-libitum access to food and water. The food was a pelletized
diet (Research Diets Services B.V., Wijk bij Duurstede, the
Netherlands) with a mild-high-fat content of 30 energy % (en%).
The fat content (en% and fat composition) corresponds to the
average human intake in the Netherlands (Dutch Food Consump-
tion Survey, 1998). The mice entered the experiment at 10 weeks
of age. After two weeks of adaptation, the quercetin group (n= 12)
received the mild-high-fat diet supplemented with 0.33% (w/w)
quercetin (Sigma, Zwijndrecht, the Netherlands) for twelve weeks.
The control group (n= 12) was given the mild-high-fat diet
without quercetin. The body weight and food intake of individual
mice were monitored on a weekly basis. After 12 weeks of
intervention all mice were fasted for two hours before anesthetisa-
tion by inhalation of 5% isoflurane. Blood was sampled via orbital
extraction in collect serum tubes (Greiner Bio-one, Longwood,
USA), which were centrifuged for 10 min at 3000 g 4uC to obtain
serum, which was stored at 280uC. After blood collection, the
mice were killed using cervical dislocation and the liver was
dissected, weighted and snap frozen in liquid nitrogen and stored
at 280uC. The experiment was performed according to the Dutch
Animal Experimentation Act (1996) and the experimental protocol
was approved by the Animal Welfare Committee of Wageningen
University, Wageningen, The Netherlands (DEC 2007080).
Figure 1. Representative pictures of hepatic lipid staining with Oil red O. There were no significant differences in lipid accumulation
between the control (A) and the quercetin (B) group. The lipid levels were comparable to mice fed a normal-fat diet (C) and much lower than the
positive control of hepatic lipid accumulation from mice fed a high-fat diet (D).
doi:10.1371/journal.pone.0051588.g001
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HPLC Analysis of Quercetin Serum Levels
HPLC with a coulometric array detector was used to measure
the amount of quercetin in serum. For this 35 ml of serum was
hydrolyzed by incubation with 15 ml of 12.5 mg/ml b-glucuron-
idase/sulfatase in 0.5 M sodium acetate (pH=5) with 5 g/l
ascorbic acid for two hours at 37uC to obtain deconjugated
quercetin, isorhamnetin and tamarixetin. Subsequently, all sam-
ples were deproteinized by mixing with 100 mL acetonitrile and
50 mL 20% H3PO4, with 3g/L ascorbic acid and centrifugation
for 10 min at 13500 rpm at 5uC. Twenty ml of the supernatant was
analyzed on a HPLC system consisting of two pumps (model L-
2100; Hitachi, Tokyo, Japan), an autosampler (Model L-2200,
Merck Hitachi), a CoulArray Module (Model 5600, ESA,
Chelmsford, MA, USA) with electrochemical channels using
carbon electrodes arranged in line and set to increasing specified
potentials (1 = 20 mV; 2= 100 mV; 3= 250 mV; 4= 500 mV)
and a thermostatic column/cell chamber set at 30uC. The
chromatography was performed on a Platinum C18 column
(EPS; 15064.6 mm, 3m, Grace Davison Sciences, Deerfield, IL,
USA) equipped with a MPLC Newguard precolumn (Brownlee
RP18 7 mm 1563.2 mm, Perkin Elmer, Shelton, CT, USA), using
a gradient elution with two mobile phases. Mobile phase A
consisted of 15% acetonitrile in 25 mM H3PO4 buffer (pH 2.4).
Mobile phase B consisted of 50% acetonitrile in 25 mM H3PO4
buffer (pH 2.4). The gradient, at a flow rate of 1.0 ml/min, was as
follows: 0–20 min, linear gradient from 0% to 100% mobile phase
B; 20–22 min, isocratic at 100% B; 22–30 min, linear return from
100 to 0% B; the total runtime was 30.0 min. Quercetin,
isorhamnetin and tamarixetin were quantified using calibration
curves made with commercially available standards.
Hepatic Lipid Staining with Oil Red O
Frozen liver sections (7 mm) were fixed with 3.7% buffered
formalin. Neutral lipids were stained with Oil red O (Sigma). The
stained areas were quantified based on a described method [17]
using Photoshop software (version 12.0.4, Adobe). Briefly, contrast
was enhanced with automatic contrast tool, red pixels were
selected with the colour range selecting tool, and total selected area
was measured in mm2. Ten to 16 pictures per animal were
quantified (n = 6–8). Controls of hepatic lipid accumulation were
liver of C57BL/6JOlaHsd mice fed a normal-fat diet (10 en% of
fat) or a high-fat diet (40 en% of fat) for twelve weeks.
Serum Lipid Analysis with Enzymatic Assays
FFA assay (Wako NEFA-HR(2) kit, Sopachem BV, Ochten,
The Netherlands) and TG assay (TG liquicolor kit, Human,
Wiesbaden, Germany) were performed as described previously
[13].
Figure 2. Cumulative serum profile of fatty acids originating from total lipids. Fatty acids were measured with GC. The levels of palmitic
acid (16:0), oleic acid (18:1(n-9)), and linoleic acid (18:2(n-6)) were significant lower in the quercetin group. Data is presented as mean6 SEM. Asterisks
indicates a significant difference between the control and the quercetin group; *** p,0.001.
doi:10.1371/journal.pone.0051588.g002
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Serum Fatty Acid Analysis with GC
Total serum fatty acids were extracted from 50 ml serum as
described [18], using dichloromethane instead of chloroform [19].
Ten mg of nonadecanoic acid methyl ester (NuCheck Prep, USA)
was added to each sample before extraction, as an internal
standard. Samples were transmethylated to fatty-esther methyl
esthers (FAME) by incubation in 1 M sodium methoxide in dry
methanol for 20 min at 80uC. The reaction mixture was then
cooled, acidified with 98% sulphuric acid and incubated for
1 hour at room temperature to methylate free acids. Lipid methyl
esters were extracted with hexane, and the hexane extracts were
subsequently dried under a nitrogen flow. Next, the residue was
dissolved in 100 ml of n-heptane and stored at 220uC under
nitrogen until analysed. All reactions were performed under
nitrogen atmosphere. GC was performed with a Trace-GC gas
chromatograph combined with AS 2000 autosampler (Thermo-
Finnigan, USA), equipped with a capillary split/splitless injector
and a flame ionization detector. Analyses of FAME were
performed on a fused-silica capillary column coated with
chemically bond stationary phase CP-Sil 88 CB (100 m,
0.32 mm I.D.). The oven temperature was programmed as
follows: from 80uC to 260uC at 2uC/min, then to 280uC at
10uC/min, where it was maintained for 45 min. The injector and
detector temperatures were set at 250uC and 270uC, respectively.
Hydrogen carrier gas was maintained at a head pressure of 70 kPa
and total flow of 44 ml/min, with a split ratio of 1:35. Integration
software Clarity version 2.4.1.57 (Data Apex Ltd. Prague, Czech
Rep.) was used for data acquisition and handling.
Serum Lipid Analysis with 1H-NMR
Total serum lipids were extracted from 20 ml of blood serum as
described [18] based on [15,16] with some adaptations to optimise
the protocol. Briefly, 20 ml of 150 mM sodium phosphate buffer
with 0.04% azide (pH=3) was added per serum sample. Then
900 ml chloroform:methanol (2:1) v/v and 900 ml 0.15 M NaCl
(pH=3) were added to the sample. Samples were shaken for 5
minutes on a horizontal shaker and centrifuged for 10 minutes at
4500 g to separate the organic and water phase. The lower
organic phase was recovered and the aqueous layer was extracted
Table 1. Fatty acid composition of the control and quercetin
diet in percentages.
Lipids Control diet (%) Quercetin diet (%)
C12:0 0.09 0.08
C14:0 1.11 1.09
C14:1 0.06 0.06
C15:0 0.08 0.08
C16:0 22.40 22.26
C16:1 1.25 1.25
C17:0 0.30 0.30
C17:1 0.19 0.15
C18:0 10.79 10.87
C18:1 trans 0.46 0.47
C18:1 33.87 33.94
C18:1 1.60 1.61
C18:2 24.23 24.21
C18:3(n-6) 0.01 0.01
C18:3 0.71 0.72
C20:0 0.23 0.22
C20:1 0.55 0.56
C20:2 0.29 0.30
C20:3(n-6) 0.05 0.05
C22:0 0.06 0.06
C20:3(n-3) 0.20 0.20
C24:0 0.06 0.06
C22:5(n-3) 0.00 0.07
C22:6(n-3) 0.02 0.03
Saturated FA 35.12 35.02
MUFA 37.98 38.04
PUFA 25.51 25.59
doi:10.1371/journal.pone.0051588.t001
Figure 3. 1H NMR difference spectrum of the quercetin-fed mice minus the control mice. Serum samples from mice exposed to quercetin
minus the 1H NMR spectra of the sera from control mice is represented by the top line. The control group is represented by the middle line and the
quercetin group is represented by the lowest line. Two representative parts of the spectrum are presented in the figure. PUFA, poly unsaturated fatty
acids; MUFA, mono unsaturated fatty acids; FA, fatty acids; TG, triglycerides; PGLY, phosphoglycerides; PC phosphatidylcholine; EC, esterified
cholesterol; TC total cholesterol.
doi:10.1371/journal.pone.0051588.g003
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again with 500 ml chloroform. The collected organic layers were
combined and evaporated to dryness using argon. The samples
were vacuum and freeze dried and dissolved in chloroform
containing 0.03% tetramethylsilane. 1H NMR was measured on a
Bruker AVANCE spectrometer operating at 600 MHz. For each
spectrum 256 (Free induction decays (FID)) transients were
collected with a flip angle of 90u, with an acquisition time of
1.82 s, a relaxation delay of 4 s, a spectral width of 30 ppm and a
standard noesy 1D pulse sequence, at 25uC, and four dummy
scans were used. The FID with 64K data points were once zero-
filled and multiplied by an exponential window function with a
0.2 Hz Line-broadening before a subsequent Fourier transforma-
tion. To all spectra a baseline correction was applied and the
spectra were aligned on the chloroform peak at 7.24 ppm.
The nature of the various resonances was based on the 1H
NMR spectra as reported [15,16]. The regions selected to quantify
the different lipid fractions were as follows; TG (4.300–
4.250 ppm), total FFA (1.380–1.198 ppm), mono unsaturated
fatty acids (MUFA) and PUFA (2CH=CH2)(5.41 to 5.27 ppm),
other PUFA than 18:2 FA (2.862–2.768 ppm), 18:2 FA including
linoleic acid (18:2(n-6)) (2.767–2.721 ppm), 18:1 and 16:1 FA
including oleic acid (18:1(n-9)) (2.050–2.011 ppm), 22:6 FA
including docosahexaenoic acid (22:6(n-3)) (2.379–2.342 ppm),
v-3 FA (0.957–0.947 ppm), phophoglycerides (PGLY) (5.258–
5.190 ppm), phosphatidylcholine (PC) (3.787–3.738 ppm), esters
of cholesterol (EC) (4.651–4.539 ppm) and total cholesterol (TC)
(0.902–0.895 ppm).
Fatty Acid Composition of Diets
Fatty acids from the diets were extracted with accelerated
solvent extraction according to the manufacturer’s protocol
(Thermo Scientific) and dissolved in toluene. Subsequently,
toluene was evaporated under nitrogen at 40uC and fatty acids
were dissolved in iso-octane (5 ml) and 200 ml 2 M KOH in
methanol was added and the mixture was shaken for one minute.
For neutralization, NaHSO4 was added and samples were shaken
for 1 minute. The iso-octane fraction (1 ml) was injected in the gas
chromatograph equipped with a capillary split injector (split ratio
1:40) and flame ionization detector. Analyses were performed on a
CP select column for FAME (50 m60.25 mm ID). The oven
temperature was programmed from 100uC to 230uC at 6uC/min.
RNA Isolation
For RNA isolation, liver was homogenized in liquid nitrogen,
total RNA was isolated using TRIzol reagent (Invitrogen, Breda,
The Netherlands) followed by purification with RNeasy columns
(Qiagen, Venlo, The Netherlands). RNA concentration and purity
were measured using a Nanodrop spectrophotometer (IsoGen Life
Science, Maarsen, The Netherlands); all RNA samples were of
high purity. RNA quality was additionally checked on the
Experion automated electrophoresis system (Bio-Rad, Veenen-
daal, The Netherlands).
Microarray Analysis
For global transcriptome analysis of liver samples, 4644 K
Agilent whole-mouse genome microarrays (G4122F, Agilent
Figure 4. Percentages of lipids present in serum per mouse
plotted for quercetin mice to control mice. Lipids were measured
with 1H NMR. Data is presented as the mean ratio of percentages of
lipids present in serum per mouse plotted for quercetin-fed (Q) mice
over control (C) mice. Total FFA were not changed, while other PUFA
than 18:2 FA, 22:6 FA, and, w-3 FA were significantly increased. TG were
significantly decreased by the quercetin diet. Data is presented as mean
6 SEM. Asterisks indicates a significant difference between the control
and the quercetin group; * p,0.05, **p,0.01, *** p,0.001. PUFA, poly
unsaturated fatty acids; MUFA, mono unsaturated fatty acids; FA, fatty
acids; TG, triglycerides; PGLY, phosphoglycerides; PC phosphatidylcho-
line; EC, esterified cholesterol; TC total cholesterol.
doi:10.1371/journal.pone.0051588.g004
Figure 5. Volcano plot of all expressed probes by global
hepatic gene expression analysis. Volcano plot of all probes
showing statistics FDR-adjusted p-values plotted against the fold
change of each probe (quercetin vs. control). Frames outline genes that
are regulated with absolute fold change .1.75 and a FDR-adjusted p-
value ,0.01; these gene symbols, names and functions are also
represented in table 1.
doi:10.1371/journal.pone.0051588.g005
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Technologies Inc., Santa Clara, CA) were used. Preparation of the
samples and the microarray hybridizations were carried out
according to the manufacturer’s protocol with a few modifications
as described previously [20]. All materials and reagents were from
Agilent Technologies, Palo Alto, USA unless stated otherwise.
Briefly, cDNA was synthesized for each animal from 1 mg RNA
using the Agilent Low-RNA Input Fluorescent Linear Amplifica-
tion Kit without addition of spikes. Thereafter, samples were split
into two equal amounts, to synthesize Cyanine 3-CTP (Cy3) and
Cyanine 5-CTP (Cy5) labelled cRNA, using half the amounts per
dye as indicated by the manufacturer. Labelled cRNA was purified
using RNeasy columns (Qiagen). All samples had a cRNA yield
higher than 825 ng and a specific activity of at least 8.0 pmol Cy-
dye per mg cRNA. Cy3-labeled cRNA samples were pooled on an
equimolar basis and used as a common reference pool. Individual
Table 2. Regulated hepatic genes with an absolute fold change .1.75 and FDR-adjusted p-value ,0.01.
Gene Symbol Gene Name Fold Change
FDR adjusted
p-value Function
I. Cyp4a14 Cytochrome P450 4a14 6.68 0.0015 v-oxidation of medium-chain fatty acids
II. Cyp4a10 Cytochrome P450 4a10 2.98 0.0083 v-oxidation of medium-chain fatty acids
III. Usp2 Ubiquitin specific peptidase 2 2.95 0.0032 regulation of intracellular protein breakdown, cell cycle regulation and
stress response
IV. Acot3 Acyl-CoA thioesterase 3 2.38 0.0018 catalysator of hydrolysis of acyl-CoAs (C12–C16) after v-oxidation to FFA
and coenzyme A
V. Por P450 (cytochrome) oxidoreductase 1.97 0.0036 electron donor for the microsomal cytochrome P450 mixed-function
oxidase system
VI. Cyp4a31 Cytochrome P450 4a31 1.90 0.0086 v-oxidation of medium-chain fatty acids
VII. Coq10b Coenzyme Q10 homolog B 1.85 0.0074 an essential electron carrier and proton translocator in the mitochondrial
respiratory chain
VIII. Insig2 Insulin-induced gene 2 21.78 0.0076 lipid and cholesterol metabolic process
IX. Spon2 Spondin 2, extracellular matrix protein21.98 0.0040 essential in the initiation of the innate immune response
X. Chka Choline kinase alpha 22.00 0.0005 phosphatidylcholine biosynthesis
doi:10.1371/journal.pone.0051588.t002
Figure 6. Microarray confirmation by RT-qPCR. The quercetin (Q)
regulated genes Cyp4a14, Cyp4a10, Acot3, Car (Nr1i3) and Por,
compared to the control (C) found by microarray analysis were
confirmed with RT-qPCR. Data is presented as mean 6 SEM (n= 12).
Asterisks indicates a significant difference between the control and
quercetin group; ** p,0.01.
doi:10.1371/journal.pone.0051588.g006
Figure 7. Schematic representation of the quercetin-regulated
genes involved in v-oxidation. Microarray and RT-qPCR analysis
showed an up regulation of Cyp4a14, Cyp4a10, Acot3, Por and Car.
Quercetin is suggested to activate Car and/or Por (dashed arrow).
Activation of the transcription factor CAR can induce the microsomal
cytochrome P450 enzymes, CYP4a14, CYP4a10 and CYP4a31, which are
important enzymes involved in v-oxidation. POR is the electron donor
for the microsomal cytochrome P450 mixed-function oxidase system.
Formed DCA by v-oxidation are further degraded by peroxisomal b-
oxidation to shorter chain fatty acids. ACOT3 is involved in the transport
of DCA into the peroxisomes by hydrolysis of long-medium chain fatty
acyl-CoA esters to FFA, which can be further transported out of
peroxisomes to mitochondria for b-oxidation or excreted in the urine.
FA, fatty acids; DCA, dicarboxylic acids.
doi:10.1371/journal.pone.0051588.g007
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825-ng Cy5-labeled cRNA and 825-ng pooled Cy3-labeled cRNA
were fragmented in 16 fragmentation and 16 blocking agent at
60uC for 30 min and thereafter mixed with GEx hybridization
buffer (HI-RPM) and hybridized in a 1:1 ratio at 65uC for 17 h in
the Agilent Microarray Hybridization Chamber rotating at
10 rpm. After hybridization, slides were washed according to the
manufacturers’ wash protocol. Arrays were scanned with an
Agilent scanner with 10 and 100% laser-power intensities.
Normalisation and Microarray Data Analysis
Signal intensities for each spot were quantified using Feature
Extraction version 9.1 (Agilent Technologies). Median density
values and background values of each spot were extracted for both
the experimental samples (Cy5) and the reference samples (Cy3).
Quality control for every microarray was performed visually by
using ‘Quality control graphs’ from Feature extraction and M-A
plots and box plots, which were made using limmaGUI in R
(Bioconductor, Wettenhal, 2004). Data were imported into
GeneMaths XT 2.0 (Applied Maths, Sint-Martens-Latem, Bel-
gium). Spots with an average Cy5 and Cy3 signal twice above
background were considered expressed and log transformed. The
Cy5 signal was normalized against the Cy3 intensity as described
before [21]. Pathway analysis was performed using MetaCore
(GeneGo, St. Joseph, Michigan, USA) and Ingenuity Systems
(Ingenuity, Redwood City, California, USA). Fold change was
expressed as the ratio of the quercetin group versus the control
group. Microarray data has been deposited in NCBI Gene
Expression Omnibus (GEO) under accession number GSE39140.
Real Time Quantitative Polymerase Chain Reaction (RT-
qPCR)
RT-qPCR was performed using the RNA of the liver samples to
validate the microarray data. One microgram of RNA of all
individual samples was used for cDNA synthesis using the iScript
cDNA synthesis kit (Bio-Rad). RT-qPCR reactions were per-
formed with iQ SYBR Green Supermix (Bio-Rad) using the MyIQ
single-colour real-time PCR detection system (Bio-Rad). Individ-
ual samples were measured in duplicate. Data were normalized
against reference genes beta-2 microglobulin (B2m) and hypoxan-
thine phophoribosyltransferase 1 (Hprt1) which were chosen based
on stable gene expression levels (geNorm, Ghent University
Hospital, Ghent, Belgium) and the microarray data. Primers were
designed using the NCBI Primer-Blast (NCBI Web site).
Sequences of the used primes were as follows: cytochrome P450
4a14 (Cyp4a14); 59-TTCTTTCGCCTGCGGAATGC-39 and 59-
CACTCCATCTGTGTGCTCGTGA-39, cytochrome P450 4a10
(Cyp4a10); 59-TCTACCCACCTGTCCCAGGC-39 and 59-
ACACCTCTGGATTTGGCCACA-39, acyl-CoA thioesterase 3
(Acot3); 59-GCTGTGACCTACCTGCTCAGTCA-39 and 59-
ATATAGAGCCATTGATGATGACAGCGG-39, cytochrome
P450 oxidoreductase (Por); 59-CGAGGGCAAGGAGCTG-
TACC-39 and 59-CACAGGTGGTCGATGGGTGG-39, consti-
tutive androstane receptor (Car; official gene symbol Nr1i3); 59-
CCGTGTTGCCTCTGCTCACA-39 and 59-GGTTAGG-
GACCGGAAGAGCG -39, beta-2-microglobulin (B2m); 59-
CCCCACTGAGACTGATACATACGC-39 and 59-
AGAAACTGGATTTGTAATTAAGCAGGTTC-39, hypoxan-
thine-guanine phosphoribosyltransferase (Hprt1); 59-TGA-
CACTGGTAAAACAATGCAAACTTTG-39 and 59-
GAGGTCCTTTTCACCAGCAAGCT -39.
Statistical Analysis
For microarray analysis, Student’s t tests were used with false
discovery rate (FDR) adjustment for multiple testing correction
according to Benjamini-Hochberg [22]. GraphPad Prism version
5.03 (Graphpad Software, San Diego, USA) was used for other
statistical analysis, with Student’s t test being used to compare the
two groups. Two-way ANOVA was used for analysis of the lipid
profiles in serum and diets, followed by a Bonferroni post hoc test.
P-values smaller than 0.05 were considered statistically significant.
Results
Body Weight, Energy Intake and Quercetin Uptake
Body weight (BW) and energy intake of the adult male mice,
which were fed a mild-high-fat diet with or without quercetin
supplementation, were not significantly different between the
quercetin and the control group during all 12 weeks. Final body
weight was 27.961.9 and 28.561.6 (mean 6 SD) gram, and
cumulative total energy intake was 45806172 and 46366207 kJ
for the quercetin and control group, respectively.
The calculated quercetin intake for the quercetin-fed mice was
,400 mg/kg BW/day. The sum of quercetin and isorhamnetin
after deconjugation in serum was 13.563.1 mM expressed as
aglycone (quercetin was 6.760.9 mM, isorhamnetin was
6.862.6 mM, and no tamarixetin was found). No quercetin was
found in serum of the control animals.
Relative liver weight was significantly lower in the quercetin-fed
mice (3.80% 60.20; p = 0.007) compared to the control mice
(4.08%60.26), while no significant differences were found for
other organs, including white adipose tissue, brown adipose tissue,
lung, heart, muscles (data not shown). Hepatic lipid staining
showed no significant differences between the quercetin and
control group (Figure 1a and b); the Oil red O recorded areas were
4806493 mm2 and 3216440 mm2, respectively. The hepatic lipid
levels were much lower than a positive control of hepatic lipid
accumulation (13,15164,410 mm2) and in the same range of
hepatic lipid levels found in liver of mice fed a normal-fat diet
(5166271 mm2) (Figure 1c and d).
Serum Lipids as Determined by Enzymatic Assays
Quantification of serum FFA and TG levels was performed
using the enzymatic FFA and TG assays, which showed a
significant decrease of 13% FFA (p,0.05) and 27% TG (p,0.05)
due to the quercetin diet. However, since quercetin has been
shown to interfere with these enzymatic assays resulting in
incorrect, apparently lower FFA and TG levels [13], two
additional analytical techniques were applied to assess serum lipid
profiles, and to check if the decreased FFA and TG levels detected
by the enzymatic assays represent real biological effects.
Serum Fatty Acid Profile as Determined by GC
GC fatty acid profiles reveales fatty acids originating from TG,
FFA, cholesteryl esters and phospholipids. The serum fatty acid
profile showed a total decrease of 7% (p,0.001) in the quercetin-
fed mice. The levels of palmitic acid (16:0), oleic acid (18:1(n-9))
and linoleic acid (18:2(n-6)) were 9–15% lower (p,0.001) in the
quercetin group (Figure 2). These are the main fatty acids in the
quercetin diet and the control diet, which were similar in terms of
fatty acid composition (Table 1). All other fatty acids that were
present in the serum showed a tendency of decreased levels due to
the quercetin treatment, except for some poly unsaturated fatty
acids (PUFA), such as arachidonic acid (20:4(n-6)) and docosahex-
aenoic acid (22:6(n-3)) which were slightly, but non significantly,
increased in the serum of quercetin-supplemented mice.
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Serum Lipid Profile as Determined by 1H NMR
1H NMR measurement reveals total TG, FFA, cholesterol and
phospholipids that are present in serum, separately. Figure 3
presents the 1H NMR difference spectrum, that is composed of the
1H NMR spectra of serum samples from mice exposed to
quercetin (n = 12) minus the 1H NMR spectra of the sera from
control mice (n = 12). The different regions (based on [15,16])
were selected to obtain information on several subsets of FFA and/
or TG, as shown in Figure 3. Integration of the respective peak
areas in the 1H NMR spectra of the individual serum samples
resulted in the amounts of the various lipids. The data are
presented in figure 4 as the mean ratio of percentages of lipids
present in serum of quercetin-fed mice as compared to control
mice. From these data it follows that upon quercetin exposure the
levels of TG are significantly decreased with 14% (p,0.001), while
some specific poly unsaturated FFA levels were increased with 11–
16%; these were PUFA other than 18:2 FA (p,0.01), 22:6 FA
(p,0.001), and v-3 FA (p,0.05). The total amount of FFA was
the same in both groups, the levels of PGLY and PC showed no
change and the EC and TC showed a slight increase, although not
significant. This implies that the overall decrease in lipid levels that
are observed in the GC analysis are due to a decrease in TG.
Quercetin Altered the Expression of Genes Involved in
Lipid Metabolism
Gene expression was analysed using whole genome gene
expression microarrays. Of the 23,256 probes being expressed,
415 probes were significantly differently expressed by quercetin
treatment (p,0.05, FDR-adjusted). Regulation of lipid metabo-
lism by quercetin was found by pathway analysis of the differently
expressed genes using the two major analysis programs, Metacore
and Ingenuity. ‘Phospholipid metabolism’ was the most signifi-
cantly regulated pathway in Metacore with a p-value of 4.8E-05
(with 3 down-regulated and 1 up-regulated gene out of 33 genes).
Ingenuity pathway analyses identified: ‘LPS/IL-1 Mediated
Inhibition of RXR Function’ as the most regulated pathway (p-
value of 5.46 E–05, with 13 up-regulated genes out of 187). In this
pathway Car is the central transcription factor and the genes, in
particular cytochromes P450, overlap partly with the ‘linoleic acid
pathway’, which is the number 3 pathway (p-value of 1.7E–03
with 4 up-regulated genes out of 83 genes) in Metacore. Although,
in each of these pathways a relative small number of genes were
regulated out of the total number of genes present, it was clear that
these regulated genes corresponded with the top significantly
regulated genes. The ten most regulated genes (absolute fold
change .1.75 and a FDR adjusted p-value ,0.01), where almost
all involved in lipid metabolism, particularly in v-oxidation of fatty
acids (Figure 5, table 2). These genes involved in v-oxidation
included Cyp4a14, Cyp4a10, Cyp4a31, Acot3 and Por. Altogeth-
er, lipid metabolism, and in particular v-oxidation, were identified
as being regulated by quercetin in the liver.
Confirmation with RT-qPCR
The quercetin induced changes in expression of Cyp4a14,
Cyp4a10, Acot3, Car, and Por that were identified by microarray
analysis, were confirmed with RT-qPCR (Figure 6). Cyp4a14,
Cyp4a10, Acot3 and Por were significantly up-regulated in the
quercetin group, while the up regulation of Car followed the same
trend, but did not reach significance.
Discussion
This study showed that chronic intake of quercetin in mice
lowered serum lipid levels which are risk factors for CVD.
Microarray analysis indicated that hepatic genes involved in lipid
metabolism, in particular in v-oxidation of fatty acids, could be
responsible for these quercetin-induced effects.
Other studies have also observed that supplementation of
quercetin to a high-fat diet decreases serum FFA and/or TG levels
in mice [10,11,12]. However, these circulating FFA and TG levels
were measured with commercial enzymatic assays, which have
recently been found to be sensitive to interference of quercetin and
its major metabolite quercetin-3-O-glucuronide, resulting in
apparently incorrect lower detected levels [13]. Here, besides
these enzymatic assays, we also used two independent analytical
methods for quantification of serum lipid profiles; GC and 1H
NMR techniques. The observed effect of quercetin on lipid levels
measured with the enzymatic FFA and TG assays (FFA -13% and
TG -27%) was higher than measured with the two analytical
techniques (GC: total fatty acids -7% and 1H NMR: FFA -2%, TG
-14%). This confirms interference of quercetin in the enzyme
based assays [13] in the physiological range of quercetin exposure
and as a consequence overestimate the lipid lowering effect of
quercetin. Nevertheless, with GC and 1H NMR a significant
reduction in serum lipid levels was found, proving that lipid
lowering is a real biological effect of quercetin. The GC data
revealed that the specific serum fatty acids palmitic acid (16:0),
oleic acid (18:1(n-9)) and linoleic acid (18:2(n-6)), originating from
total lipids, were all significantly decreased in the quercetin-fed
mice. Moreover, with 1H NMR, serum lipids were measured
separately, which revealed that serum TG levels of the quercetin
group were significantly decreased, while total FFA, cholesterol
and phospholipid levels remained unchanged. This indicates that
the decreased levels of palmitic acid (16:0), oleic acid (18:1(n-9))
and linoleic acid (18:2(n-6)) found by GC originated from TG.
Moreover, the 1H NMR data showed unchanged levels of total
FFA and increased levels of PUFA in the serum of the mice on the
quercetin diet, which indicate a shift from saturated fatty acids to
PUFA, which are known as the more healthy fatty acids. Together,
these data proved that quercetin significantly reduced serum lipid
levels and resulted in a more beneficial lipid profile.
The increased levels of PUFA and the decreased levels of
saturated fatty acids cannot be fully explained by the microarray
data. Genes involved in beta oxidation or specific desaturases were
not differentially regulated by the quercetin diet.
There were no significant differences found in the serum
phospholipid levels, while pathway analysis revealed phospholipid
metabolism as a regulated pathway. However, based on gene
expression it was not clear how phospholipid metabolism would be
affected, since up as well down regulated genes were observed in
different parts of this pathway, and a relative small number of
genes of the total pathway was regulated. Therefore, it was
concluded that this was not a crucial pathway in this study.
Quercetin induced a decrease in relative liver weight in our study.
This decrease cannot be explained by a decrease in hepatic lipid
accumulation, because hepatic lipid levels were not affected by
quercetin. Other studies [11,12] have shown a decrease in lipid
accumulation in liver upon dietary administration of quercetin and
thus seem to be in contrast with our study. While a study with
mulberry leaves, high in quercetin, did report unmodified lipid
accumulation in the liver [23] and is thus in line with our data.
The differences may be explained by the diets used in the different
studies. We have used a mild-high-fat diet rich in unsaturated fatty
acids, which did not result in extensive lipid accumulation in the
liver, since the found hepatic lipid levels were in the same range as
found for mice fed a normal-fat diet. The other studies that show a
quercetin induced decrease in lipid accumulation used a high
saturated fatty acid rich diet which induced lipid accumulation in
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the liver [11,12]. This suggests that quercetin may prevent lipid
accumulation in the liver under adverse dietary conditions, but not
with relatively healthy diets. In general, quercetin induced altered
lipid metabolism on a mild-high-fat diet (our study), a normal-fat
diet [10], and different high-fat diets [11,12]. Suggesting, that
quercetin can affect lipid metabolism independent of the diet,
although the impact of this effect can be different.
Using whole genome microarrays and confirmation by RT-
qPCR, we showed that quercetin up-regulates Cyp4a10, Cyp4a14,
Cyp4a31, Acot3, Por, and, possibly Car. An integration of these
genes into a single ‘hepatic pathway’ differentially expressed by
quercetin treatment is proposed in Figure 7. Normally, fatty acids
are mainly metabolized by b-oxidation first in peroxisomes (very
long chain FFA) and subsequently in mitochondria (long, medium,
and short chain FFA). Another type of fatty acid oxidation is v-
oxidation, which occurs in the endoplasmatic reticulum by
members of the cytochrome P450 4A family [24]. Omega-
oxidation becomes more important during periods of increased
influx of fatty acids into the liver, for example in our high-fat diet
mice study, in obesity, and when the mitochondrial oxidation
system is insufficient to metabolize fatty acids [25,26]. In these
situations v-oxidation can prevent lipid toxicity [27]. Fatty acids
oxidized by v-oxidation result in v-hydroxy fatty acids which are
then dehydrogenated to a dicarboxylic acid in the cytosol. These
dicarboxylic acids are further degraded by peroxisomal b-
oxidation to shorter chain dicarboxylic fatty acids, which can be
excreted in the urine, metabolized by the peroxisomal oxidation
system to succinate and acetyl CoA, or completely oxidized after
transport into the mitochondrial b-oxidation system [28]. A small
increase of ketone bodies was found in the quercetin-fed mice
suggesting an increase of b-oxidation (292.56199.2 versus
185.66118.1 mM, p= 0.12).
Acot3 was also up-regulated in our study, and the enzyme
ACOT3 hydrolyses long-medium chain fatty acyl-CoA esters to
FFA, and thus facilitate transport into peroxisomes. The FFA can
subsequently be transported out of peroxisomes to mitochondria
for further b-oxidation [29,30].
It has been described that, among others, palmitic acid (16:0)
and oleic acid (18:1(n-9)) can be hydroxylated by CYP4A11, the
human variant of murine Cyp4a10 [31]. This is especially
consistent with the serum fatty acid profile obtained in the present
study (Figure 2), where levels of palmitic acid (16:0) and oleic acid
(18:1(n-9)) were significantly lower in the quercetin-fed mice. The
significant up regulation of Cyp4a10, Cyp4a14, Cyp4a31 and
Acot3 therefore explains the observed reduced serum levels for
these specific fatty acids.
In humans, various polymorphisms are described in the genes of
cytochromes P450s and they can be considered as one of the major
determinants of individual susceptibility to CVDs [32]. Allelic
variations in CYP4A11 are suggested to result in an increased risk
for hypertension [25,32]. Hypertension can be caused by
increased serum lipid levels [6], which were decreased by
quercetin in our study with concomitant up regulation of Cyp4a
genes.
The up regulation of the Cyp4a genes is consistent with the
significant, 1.97 fold up regulation of Por by quercetin. POR is an
enzyme that is required for electron transfer to cytochrome P450
enzymes and is therefore rate limiting for P450 enzymes. Deletion
of the Por gene in a mouse model reduced hepatic P450 activity by
more than 95%. Moreover, hepatic Por knockout (Por-KO) mice
showed decreased CYP4A protein levels, and an enlarged and
fatty liver. Based on these observations, it was concluded that the
P450 system plays a major role in regulating lipid homeostasis and
hepatic lipid levels [33,34]. Two to three-fold more genes were
significantly regulated when WT mice were exposed to quercetin
compared to Por-KO mice. These genes were, among others,
involved in fatty acid metabolism pathways. This suggests that
hepatic POR mediates many of the biological effects of quercetin,
including fatty acid metabolism [35]. These results underscores
our data, which showed an up regulation of Por.
It is also suggested that P450 expression can be mediated via a
CAR-dependent signaling pathway [36]. CAR is a transcription
factor that is highly expressed in the liver. It is shown that ligand
dependent activation of CAR increased lipid metabolism in
rodents [37,38] and it is also shown that this can lead to
specifically increased expression of genes involved in v-oxidation
[39]. Furthermore, exposure of quercetin to HepG2 cells
transfected with CAR showed that CAR can be activated by
quercetin [40,41]. Our data showed significant up regulation of
Car (FC= 1.37, FDR adjusted p-value = 0.005), which suggests
that Car has an important role in quercetin mediated regulation of
lipid metabolism.
This study used male mice, therefore caution is needed in
translating these data to female mice. It is known that there are sex
differences in the sensitivity to CAR activators and also Cyp4a
genes can be under sex-dependent control [42,43]. In conclusion,
quercetin can affect hepatic lipid metabolism, especially v-
oxidation. This is shown by the up regulation of Cyp4a10,
Cyp4a14, Cyp4a31, Acot3, Por and the transcription factor Car.
These effects are associated with decreased corresponding
circulating lipid levels, which may contribute to potential
beneficial effects on CVD.
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